Is there a role for melatonin in fibromyalgia?

Fibromyalgia, characterised by persistent pain, fatigue, sleep disturbance and cognitive dysfunction, is a central sensitivity syndrome that also involves abnormality in peripheral generators and in the hypothalamic pituitary adrenal axis. Heterogeneity of clinical expression of fibromyalgia with a multifactorial aetiology has made the development of effective therapeutic strategies challenging. Physiological properties of the neurohormone melatonin appear related to the symptom profile exhibited by patients with fibromyalgia and thus disturbance of it’s production would be compatible with the pathophysiology. Altered levels of melatonin have been observed in patients with fibromyalgia which are associated with lower secretion during dark hours and higher secretion during daytime. However, inconsistencies of available clinical evidence limit conclusion of a relationship between levels of melatonin and symptom profiles in patients with fibromyalgia. Administration of melatonin to patients with fibromyalgia has demonstrated suppression of many symptoms and an improved quality of life consistent with benefit as a therapy for the management of this condition. Further studies with larger samples, however, are required to explore the potential role of melatonin in the pathophysiology of fibromyalgia and determine the optimal dosing regimen of melatonin for the management of fibromyalgia

Energetics of halogen bonding of group 10 metal fluoride complexes.

A study is presented of the thermodynamics of the halogen-bonding interaction of C(6)F(5)I with a series of structurally similar group 10 metal fluoride complexes trans-[Ni(F)(2-C(5)NF(4))(PCy(3))(2)] (2), trans-[Pd(F)(4-C(5)NF(4))(PCy(3))(2)] (3), trans-[Pt(F){2-C(5)NF(2)H(CF(3))}(PR(3))(2)] (4a, R = Cy; 4bR = iPr) and trans-[Ni(F){2-C(5)NF(2)H(CF(3))}(PCy(3))(2)] (5a) in toluene solution. (19)F NMR titration experiments are used to determine binding constants, enthalpies and entropies of these interactions (2.4 ≤ K(300) ≤ 5.2; -25 ≤ ΔH(o) ≤ -16 kJ mol(-1); -73 ≤ ΔS(o) ≤ -49 J K(-1) mol(-1)). The data for -ΔH(o) for the halogen bonding follow a trend Ni < Pd < Pt. The fluoropyridyl ligand is shown to have a negligible influence on the thermodynamic data, but the influence of the phosphine ligand is significant. We also show that the value of the spin-spin coupling constant J(PtF) increases substantially with adduct formation. X-ray crystallographic data for Ni complexes 5a and 5c are compared to previously published data for a platinum analogue. We show by experiment and computation that the difference between Pt-X and Ni-X (X = F, C, P) bond lengths is greatest for X = F, consistent with F(2pπ)-Pt(5dπ) repulsive interactions. DFT calculations on the metal fluoride complexes show the very negative electrostatic potential around the fluoride. Calculations of the enthalpy of adduct formation show energies of -18.8 and -22.8 kJ mol(-1) for Ni and Pt complexes of types 5 and 4, respectively, in excellent agreement with experiment

Development and characterization of 430L matrix composites gradient materials

This paper deals with a new concept that is Functionally Gradient Materials (FGM). The materials developed in this work are constituted by a 430L matrix core and composite materials with this matrix and gradient concentration with NbC reinforcement, from the core to the surface, through different steps. Composite powders of different content in NbC were produced through high energy milling in order to obtain the gradient composition. The morphology and microhardness of these powders were characterised and subsequently were processed through conventional P/M techniques, pressing and sintering. The materials obtained show improved wear behaviour